Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:BIOC

Biocept (BIOC) Stock Price, News & Analysis

Biocept logo

About Biocept Stock (NASDAQ:BIOC)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.43
$1.67
52-Week Range
N/A
Volume
751,400 shs
Average Volume
764,067 shs
Market Capitalization
$1.14 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive BIOC Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Biocept and its competitors with MarketBeat's FREE daily newsletter.

BIOC Stock News Headlines

The Trump Dump is starting; Get out of stocks now?
The first 365 days of the Trump presidency… Will be the best time to get rich in American history.
See More Headlines

BIOC Stock Analysis - Frequently Asked Questions

Biocept, Inc. (NASDAQ:BIOC) posted its quarterly earnings data on Monday, November, 15th. The medical research company reported $0.90 earnings per share (EPS) for the quarter, missing the consensus estimate of $2.70 by $1.80. The medical research company earned $17.47 million during the quarter, compared to analyst estimates of $16.87 million.

Shares of Biocept reverse split on Wednesday, May 17th 2023.The 1-30 reverse split was announced on Wednesday, May 17th 2023. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 17th 2023. An investor that had 100 shares of stock prior to the reverse split would have 3 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Biocept investors own include Advanced Micro Devices (AMD), Sorrento Therapeutics (SRNE), T2 Biosystems (TTOO), VBI Vaccines (VBIV), Vaxart (VXRT), NIO (NIO) and iBio (IBIO).

Company Calendar

Last Earnings
11/15/2021
Today
7/04/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Diagnostics & Research
Sub-Industry
N/A
Current Symbol
NASDAQ:BIOC
Employees
50
Year Founded
1993

Profitability

Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$32.09 million
Pretax Margin
-564.02%

Debt

Sales & Book Value

Annual Sales
$25.86 million
Price / Cash Flow
N/A
Book Value
$15.60 per share
Price / Book
N/A

Miscellaneous

Free Float
2,584,000
Market Cap
$1.14 million
Optionable
Not Optionable
Beta
0.69

Social Links

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report

This page (NASDAQ:BIOC) was last updated on 7/5/2025 by MarketBeat.com Staff
From Our Partners